 PolyPid Ltd NASDAQ: PYPD has announced preclinical data in two key Glioblastoma Multiform GBM animal models of its OncoPLEX intra-tumoral cancer therapy program. OncoPLEX is designed to provide controlled local exposure to docetaxel, one of the most widely used chemotherapy agents. 